Skip to main content
Log in

Intranasal glucagon treatment relieves hypoglycaemia in children with Type 1 (insulin-dependent) diabetes mellitus

  • Originals
  • Published:
Diabetologia Aims and scope Submit manuscript

Summary

The aim of the present study was to compare intranasal glucagon with subcutaneous glucagon as a treatment of insulin-induced hypoglycaemia in 11 children, 7–12 years old, with Type 1 (insulin-dependent) diabetes mellitus. Hypoglycaemia (1.6±0.1 vs 1.8±0.2 mmol/l) was induced twice in each child by continuous insulin and variable glucose infusions. One milligram of intranasal glucagon or 0.5 mg of subcutaneous glucagon was given in a randomized order. At 15 min after the administrations of either intranasal or subcutaneous glucagon, the blood glucose concentration increased by 1.5±0.2 mmol/l or 1.7±0.2 mmol/l above the glucose nadir, respectively. After nasal administration, the maximal rise in blood glucose was seen after 25 min. Subcutaneous injections induced higher and more sustained plasma glucagon concentrations but the children suffered more often from nausea than when they were treated intranasally. In conclusion, treatment with intranasal glucagon seems to be efficient and results in a rapid correction of insulin-induced hypoglycaemia with few side-effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Egger M, Gschwend S, Smith GD, Zuppinger K (1991) Increasing incidence of hypoglycemic coma in children with IDDM. Diabetes Care 14: 1001–1005

    CAS  PubMed  Google Scholar 

  2. Åman J, Karlsson I, Wranne L (1989) Symptomatic hypoglycaemia in childhood diabetes: a population-based questionnaire study. Diabetic Med 6: 257–261

    PubMed  Google Scholar 

  3. The DCCT research group (1987) Diabetes control and complications trial (DCCT): results of feasibility study. Diabetes Care 10: 1–19

    Google Scholar 

  4. Reichard P, Berglund A, Britz A, Levander S, Rosenqvist U (1991) Hypoglycaemia episodes during intensified insulin treatment: increased frequency but no effect on cognitive function. J Intern Med 229: 9–16

    CAS  PubMed  Google Scholar 

  5. Ryan C, Vega A, Drash A (1985) Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 75: 921–927

    CAS  PubMed  Google Scholar 

  6. Rovet JF, Ehrlich RM, Hoppe M (1987) Intellectual deficits associated with early onset of insulin-dependent diabetes in children. Diabetes Care 10: 510–515

    CAS  PubMed  Google Scholar 

  7. Golden M, Ingersoll G, Brack C, Russell C, Wright J, Huberty T (1989) Longitudinal relationship of asymptomatic hypoglycemia to cognitive function in IDDM. Diabetes Care 12: 89–93

    CAS  PubMed  Google Scholar 

  8. Langan SJ, Deary IJ, Hepburn DA, Frier BM (1991) Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 34: 337–344

    Article  CAS  PubMed  Google Scholar 

  9. Wredling R, Levander S, Adamson U, Lins PE (1990) Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 33: 152–157

    Article  CAS  PubMed  Google Scholar 

  10. Mühlhauser I, Berger M, Sonnenberg G, Koch J, Jörgens V (1985) Incidence and management of severe hypoglycaemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care 8: 268–273

    PubMed  Google Scholar 

  11. Åman J, Wranne L (1988) Hypoglycaemia in childhood diabetes. Effect of subcutaneous or intramuscular injection of different doses of glucagon. Acta Paediatr Scand 77: 548–553

    PubMed  Google Scholar 

  12. Pontiroli A, Alberetto M, Pozza G (1984) Metabolic effects of intranasally administered glucagon: comparison with intramuscular and inravenous injecton. Acta Diabetol Lat 22: 103–110

    Google Scholar 

  13. Slama G, Alamowitch C, Desplanque N, Letanoux M, Zirinis P (1990) A new non-invasive method for treating insulin-reaction: intranasal lyophylized glucagon. Diabetologia 33: 671–674

    Article  CAS  PubMed  Google Scholar 

  14. Slama G, Reach G, Cahane M, Quetin C, Villanove-Robin F (1992) Intranasal glucagon in the treatment of hypoglycaemic attacks in children: experience at a summer camp. Diabetologia 35: 398 (Letter)

    Article  CAS  PubMed  Google Scholar 

  15. Jørgensen S, Sørensen AR, Kimer LL, Mygind N (1991) A new non-invasive method for treating insulin-reaction: intranasal lyophylized glucagon. Diabetes 40: A2190 (Abstract)

    Google Scholar 

  16. Faloona G, Unger R (1974) Glucagon. In: Jaffe B, Behrman H (eds) Methods of hormone radioimmunoassay. Academic Press, New York, pp 317–330

    Google Scholar 

  17. Poulsen F, Jørgensen PN, Bucher D (1987) A two-site enzyme immunoassay (EIA) using biotin-labelled antibody and avidinperoxidase conjugate for human insulin in serum. Ann Clin Biochem [Suppl 2]: 246–247

    Google Scholar 

  18. Jeppsson JO, Jerntorp P, Sundkvist G, Englund H, Nylund V (1986) Measurement of HbA1c by a new lipuid-chromatographic assay: methodology, clinical utility and relation to glucose tolerance evaluated. Clin Chem 32: 1867–1872

    CAS  PubMed  Google Scholar 

  19. Gunning RR, Garber AJ (1978) Bioactivity of instant glucosefailure of absorption through oral mucosa. JAMA 240: 1611–1612

    Article  CAS  PubMed  Google Scholar 

  20. Åman J, Wranne L (1984) Treatment of hypoglycaemia in diabetes: failure of absorption of glucose through rectal mucosa. Acta Paediatr Scand 73: 560–561

    PubMed  Google Scholar 

  21. Daneman D, Frank M, Perlman K, Tamm J, Erlich R (1989) Severe hypoglycemia in children with insulin-dependent diabetes mellitus: frequency and predisposing factors. J Pediatr 115: 681–685

    CAS  PubMed  Google Scholar 

  22. Rosenfalck AM, Bendtson I, Jørgensen S, Binder C (1992) Nasal glucagon in the treatment of hypoglycaemia in type 1 (insulin-dependent) diabetic patients. Diab Res Clin Pract 17: 43–50

    Article  CAS  Google Scholar 

  23. Onyang A, Cohen S (1981) Effects of hormones on gastro-intestinal motility. Med Clin North Am 217: 1111–1127

    Google Scholar 

  24. Aylet P (1962) Gastric emptying and change of blood glucose level, as effected by glucagon and insulin. Clin Sci 22: 171–178

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stenninger, E., Åman, J. Intranasal glucagon treatment relieves hypoglycaemia in children with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36, 931–935 (1993). https://doi.org/10.1007/BF02374475

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02374475

Key words

Navigation